EOFLOW v Insulet (CoA, 18 March 2026)
| Date | 18 March 2026 |
|---|---|
| Court | CoA |
| Division | Luxembourg (LU) |
| Type of action | Appeal RoP220.2 |
| Case number(s) | UPC_CoA_930/2025 |
| Registry reference | UPC-COA-0000930/2025 |
| Parties | EOFLOW Co., Ltd. v. Insulet Corporation |
Official decision (PDF) · UPC registry entry
Case timeline
- 29 January 2026 : EOFlow v Insulet (CoA, 29 January 2026) UPC-COA-0000930/2025
- 4 February 2026 : EOFlow v Insulet (CoA, 4 February 2026) UPC_CoA_930/2025
Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.
Dhenne Avocats · 10 October 2026
Our analysis
Summary
In an order of 18 March 2026 (UPC_CoA_930/2025), the UPC Court of Appeal dismissed EOFlow Co., Ltd.’s appeal against the Milan Central Division order of 4 December 2025 (UPC_CFI_1167/2025), which had refused to treat as confidential under Rule 262.2 business information disclosed to Insulet Corporation in compliance with an order to provide information (EP 4 201 327). The court held that there is no implicit limitation on the use of information received from the other side: only an order under Rule 262A restricts such use. For a party obliged to disclose sensitive data, the lesson is plain: protection must be sought before disclosure.
Question
Can business information disclosed to the opponent without a protective order still be withheld from the public under Rule 262.2?
Decision
A trade secret requires information that is secret, has commercial value because it is secret and has been subject to reasonable steps to keep it secret (paragraph 18, Article 39(2) TRIPS). Rules 262 and 262A also cover other confidential information (paragraph 23). The court rejected the notion of an implicit procedural restriction: information received without restriction is no longer a trade secret or other confidential information (paragraphs 26 and 27). A Rule 262.2 request does not protect against disclosure to the other party. Only Rule 262A does (paragraph 29), and EOFlow had not sought such an order, having even stated that it was unnecessary (paragraph 30). The assertion about the content of a settlement, already set out in a published order, is public (paragraphs 31 to 33). The appeal was dismissed and EOFlow must bear Insulet’s costs of the appeal.
Key points for practice
- A party ordered to disclose information should apply for a Rule 262A order before handing it over. Otherwise it can no longer keep that information from the public (paragraphs 26 to 30).
- Information already set out in a published decision can no longer be protected as a trade secret (paragraph 33).
Provisions applied
- Agreement on a Unified Patent Court
- Art. 24(1)(d), Art. 58 and Art. 69(1)
- Rules of Procedure
- Rules 262.1(b), 262.2 and 262A
- Other provisions
- Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS), Art. 39(2), Directive (EU) 2016/943
- Case law cited
- Court of Appeal, Strabag v Swarco Futurit, 1 August 2025, UPC_CoA_70/2025, Court of Appeal, Kodak v Fujifilm, 14 October 2025, Court of Appeal, Docket Navigator v Syngenta, 19 December 2025, Court of Appeal, Gowling WLG (Boe v Zentiva Portugal), 24 February 2026, Court of Appeal, Meril v Swat, 5 May 2025, UPC_CoA_634/2024, Court of Appeal, EOFlow v Insulet, 29 January 2026
Related decisions
Prepared by Dhenne Avocats from the official decision, consulted on 10 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.
Decisions in the same proceedings
Going further
Lexicon: UPC Court of Appeal, Supplementary protection certificate (SPC), Biosimilar medicinal product, Launch at risk.
Dhenne Avocats blog: UPC Appeals: What the Numbers Show, Pharmaceutical patents and the UPC: is the Court hostile to them?.
Publications by Matthieu Dhenne: The Launch Letter: How Generics and Biosimilars Should Write to Avoid UPC Urgency (Kluwer Patent Blog).
Source and translations
- Official source
- Unified Patent Court registry link recorded in the record
- Original language
- not recorded
- Translation available
- no translation recorded the firm’s French record is a summary, not a translation
- Date checked
- not recorded
Follow this case
Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.
Proceedings
UPC_CoA_930/2025official number
UPC_CFI_1167/2025Parties
- defendantInsulet Corporation26 decisions in the corpusFollow this party
- claimantEOFLOW Co., Ltd.22 decisions in the corpusFollow this party
Decisions in the same proceedings and documented appeals
- 4 December 2025 Insulet v EOFLOW (CFI, 4 December 2025) Application RoP262A · UPC_CFI_1167/2025
The Milan Central Division ordered EOFLOW to pay a penalty of EUR 150,000 for violating the preliminary injunction granted by the Court of Appeal on 30 April 2025, on the basis of evidence that EOFLOW had exported 11,520 insulin pump devices to Italy and Sweden between May and July 2025 in breach of that injunction, an…
- 29 January 2026 EOFlow v Insulet (CoA, 29 January 2026) Application RoP262.2 · UPC_CoA_930/2025
Les pièces déposées comme confidentielles sont rendues accessibles à l’autre partie et la demande de restriction d’usage est rejetée : les informations communiquées en exécution d’une injonction ne sont protégées que par une demande au titre de la règle 262A.
- 4 February 2026 EOFlow v Insulet (CoA, 4 February 2026) Appeal RoP220.2 · UPC_CoA_930/2025 · appeal, first-instance number cited in the decision
L’appel contre l’ordonnance prononçant une astreinte et fixant les frais est irrecevable faute d’autorisation expresse de la division de première instance. La demande d’effet suspensif est rejetée.
- 18 March 2026 EOFLOW v Insulet (CoA, 18 March 2026) Appeal RoP220.2 · UPC_CoA_930/2025 · appeal, first-instance number cited in the decision
What the record states
- Nature of the act
- Appeal RoP220.2
- Outcome (Dhenne Avocats summary)
- La cour d'appel rejette l'appel d'EOFlow : les informations communiquées à Insulet sans ordonnance au titre de la règle 262A ne sont plus des secrets d'affaires ni des informations confidentielles, aucune limitation implicite d'usage n'existant.
- Appeal
- Decision of the Court of Appeal (first instance cited: UPC_CFI_1167/2025).
- Instance
- Court of Appeal decision.
Patents mentioned
EP 4 201 327mentioned in: Dhenne Avocats analysis Follow this patent
Related decisions cited in the analyses
- Gowling WLG v Boehringer Ingelheim International (CoA, 24 February 2026) cited in this record
- EOFlow v Insulet (CoA, 4 February 2026) cited in this record
- EOFlow v Insulet (CoA, 29 January 2026) cited in this record
- Docket Navigator (applicant) in Sumi Agro v Syngenta (CoA, 19 December 2025) cited in this record
- Kodak v Fujifilm (CoA, 14 October 2025) cited in this record
- CA v Deutsche Telekom (CFI, 15 July 2026) cites this decision
- InterDigital VC Holdings v The Walt Disney Company (CFI, 16 June 2026) cites this decision
- Insulet v EOFLOW (CFI, 12 June 2026) cites this decision
- Dolby International v CPYou (CFI, UPC_CFI_1536/2025, 1 May 2026, doc. 3) cites this decision
- QUANTIFICARE v Canfield Scientific (CFI, UPC_CFI_559/2024, 23 April 2026) cites this decision
- Yangtze Memory v Micron (CFI, 1 April 2026) cites this decision
Patents and standards
| Publication | Role in the dispute | Family | Standard and declaration | Pool | Sources |
|---|---|---|---|---|---|
EP 4 201 327Fluid delivery device with transcutaneous access tool, insertion mechanism and blood glucose monitoring for use therewith recorded proprietor: Insulet Corp | Mentioned in the analysis (role not qualified) Also mentioned in 25 other decision(s): EOFLOW v Insulet (CFI, 22 July 2025) · EOFlow v Insulet (CoA, 26 February 2026) · EOFlow v Insulet (CoA, 4 February 2026) · EOFlow v Insulet (CoA, 29 January 2026) · Herbert Smith Freehills Kramer (applicant) in Insulet v EOFLow (CoA, 2 · Insulet v EOFLOW (CFI, 15 October 2025) · EOFLOW v Insulet (CFI, ORD_26828/2025, 5 June 2025) · EOFLOW v Insulet (CFI, 28 May 2025) | not recorded | not recorded | not recorded | Espacenet · European Patent Register existence and title of the publication checked on 30 October 2026 (Google Patents, Espacenet and Register links are not checked automatically) mentioned in: Dhenne Avocats analysis |
Receive an alert
Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.